68 filings
8-K
ME
23andMe Holding Co - Ordinary Shares
10 Jun 24
Regulation FD Disclosure
4:17pm
8-K
ME
23andMe Holding Co - Ordinary Shares
3 Jun 24
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO
8:06am
8-K
ME
23andMe Holding Co - Ordinary Shares
24 May 24
Departure of Directors or Certain Officers
4:06pm
8-K
ME
23andMe Holding Co - Ordinary Shares
23 May 24
23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
4:07pm
8-K
ME
23andMe Holding Co - Ordinary Shares
10 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
zmdr jlh9qp
18 Apr 24
23andMe announces CEO’s intention to pursue a potential take-private
8:07am
8-K
l4puginn cnj7o0
29 Mar 24
Departure of Directors or Certain Officers
12:46pm
8-K
xuyjt888 pztk6vky6uc
7 Feb 24
23andMe Reports Third Quarter Fiscal 2024 Financial Results
4:03pm
8-K
5f7wcgp 8mrubatysp
31 Jan 24
23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
7:50am
8-K
jjsvc
8 Jan 24
Regulation FD Disclosure
7:45am
8-K/A
rh46f277qaevf cqm
1 Dec 23
Regulation FD Disclosure
4:06pm
8-K
c1d1kypjhj qrl8f
13 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
a9styb io
8 Nov 23
23andMe Reports Second Quarter Fiscal 2024 Financial Results
4:29pm
8-K
srih06
6 Nov 23
23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1
8:15am
8-K
n0hyo
30 Oct 23
23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK
4:05pm
8-K
xddi kltth1b
27 Oct 23
Departure of Directors or Certain Officers
4:06pm
8-K
g01cpvn5jl7sziam
10 Oct 23
Regulation FD Disclosure
4:17pm
8-K
eiv7i51drfs08rnmy4
19 Sep 23
Departure of Directors or Certain Officers
4:06pm
8-K
xm02f2 q0uc4rzo
11 Sep 23
Departure of Directors or Certain Officers
4:06pm
8-K
ofqua7x9nnqr 1ora0
1 Sep 23
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
12:00am